Medigene Management

Management criteria checks 1/4

Medigene's CEO is Selwyn Ho, appointed in Jul 2022, has a tenure of 1.75 years. total yearly compensation is €612.47K, comprised of 25.6% salary and 74.4% bonuses, including company stock and options. directly owns 0.5% of the company’s shares, worth €185.11K. The average tenure of the management team and the board of directors is 1.4 years and 6.7 years respectively.

Key information

Selwyn Ho

Chief executive officer

€612.5k

Total compensation

CEO salary percentage25.6%
CEO tenure1.8yrs
CEO ownership0.5%
Management average tenure1.4yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Selwyn Ho's remuneration changed compared to Medigene's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-€16m

Sep 30 2023n/an/a

-€23m

Jun 30 2023n/an/a

-€29m

Mar 31 2023n/an/a

-€19m

Dec 31 2022€612k€157k

-€8m

Compensation vs Market: Selwyn's total compensation ($USD656.38K) is above average for companies of similar size in the German market ($USD401.52K).

Compensation vs Earnings: Insufficient data to compare Selwyn's compensation with company performance.


CEO

Selwyn Ho (52 yo)

1.8yrs

Tenure

€612,472

Compensation

Dr. Selwyn Ho, MBBS, serves as Chief Executive Officer & Member of the Executive Management Board at Medigene AG since July 25, 2022. He served as Chief Business Officer at Connect Biopharma Holdings Limit...


Leadership Team

NamePositionTenureCompensationOwnership
Selwyn Ho
CEO & Member of Executive Management Board1.8yrs€612.47k0.50%
€ 185.1k
Dolores Schendel
Chief Scientific Officer9.9yrs€624.00kno data
Ernst-Ludwig Winnacker
Co-Founder & Chairman Scientific Advisory Boardno data€20.00kno data
Birger Kohlert
Chief Financial Officerno datano datano data
Pamela Keck
Vice President of Investor Relations & Corporate Communications1.1yrsno datano data
Kirsty Crame
VP and Head of Clinical Research & Development1.1yrsno datano data

1.4yrs

Average Tenure

Experienced Management: MDG1's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Ernst-Ludwig Winnacker
Co-Founder & Chairman Scientific Advisory Board6.7yrs€20.00kno data
Anthony Man
Independent Member of the Supervisory Board3.3yrs€21.00kno data
Antoinette Hiebeler-Hasner
Independent Deputy Chairwomen of the Supervisory Board7.7yrs€36.00kno data
Gerd Zettlmeissl
Independent Chairman of the Supervisory Board6.9yrs€46.00kno data
Ronald Scott
Independent Member of the Supervisory Board6.9yrs€24.00kno data
Frank Mathias
Independent Member of the Supervisory Board5.9yrs€30.00k0.085%
€ 31.5k
Peter Krammer
Member of Scientific Advisory Board6.7yrsno datano data
Lawrence Samelson
Member of Scientific Advisory Board6.7yrsno datano data
Micha Drukker
Member of Scientific Advisory Board6.7yrsno datano data
Freda Stevenson
Member of Scientific Advisory Board6.7yrsno datano data
Jolanda de Vries
Member of Scientific Advisory Board6.7yrsno datano data

6.7yrs

Average Tenure

67yo

Average Age

Experienced Board: MDG1's board of directors are considered experienced (6.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.